Improved treatment satisfaction after switching therapy to rituximab in relapsing–remitting MS

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

(2016) Peter Alping et al.   ANNALS OF NEUROLOGY

Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab

(2016) Pierre de Flon et al.   NEUROLOGY

Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes

(2015) Jan Lycke   Therapeutic Advances in Neurological Disorders

Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis

(2014) Sandra Meyer-Moock et al.   BMC Neurology

The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis

(2014) J. Van Schependom et al.   EUROPEAN JOURNAL OF NEUROLOGY

A changing treatment landscape for multiple sclerosis: challenges and opportunities

(2014) F. Piehl   JOURNAL OF INTERNAL MEDICINE

Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis

(2014) Edward Fox et al.   Multiple Sclerosis and Related Disorders

Individualizing treatment goals and interventions for people with MS

(2012) Gavin Giovannoni et al.   CURRENT OPINION IN NEUROLOGY

A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence

(2012) Carla Dias-Barbosa et al.   Patient Preference and Adherence

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

(2010) V. Devonshire et al.   EUROPEAN JOURNAL OF NEUROLOGY

Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)

(2009) Melina Ramp et al.   Health and Quality of Life Outcomes

Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications

(2009) Murtuza Bharmal et al.   Health and Quality of Life Outcomes

Compliance, adherence, and the treatment of multiple sclerosis

(2009) Thomas Klauer et al.   JOURNAL OF NEUROLOGY

The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue

(2009) IK Penner et al.   Multiple Sclerosis Journal

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE